The purpose of this study is to collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of painful impending and actual fractures of the humerus secondary to metastatic cancer.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
14
Treatment of impending and actual pathological fractures of the humerus
Medical University of Vienna
Vienna, Austria
St. Vinzenz-Hospital GmbH
Cologne, Germany
Johannes Wesling Klinikum Minden
Minden, Germany
Lahn-Dill Kliniken
Wetzlar, Germany
Pain Reduction
VAS Pain Score change of \> -33% compared to baseline
Time frame: 90 days
Functional Improvement (Barthel Index of Activities of Daily Living (ADLs) improvement of > +10% from baseline -EORTC QLQ-C30 improvement of > +10% from baseline -EORTC QLQ-BM22 improvement of > +10% from baseline)
* Barthel Index of Activities of Daily Living (ADLs) improvement of \> +10% from baseline * EORTC QLQ-C30 improvement of \> +10% from baseline * EORTC QLQ-BM22 improvement of \> +10% from baseline
Time frame: 90 days
Clinical Safety Success (No Serious Device Related Complications -No additional surgical interventions: revisions, supplements, fixations or removals)
* No Serious Device Related Complications * No additional surgical interventions: revisions, supplements, fixations or removals
Time frame: 90 days
Radiographic Safety Success (No device fracture, migrations, mal-alignment or loss of reduction or fixation)
No device fracture, migrations, mal-alignment or loss of reduction or fixation
Time frame: 90 days
Pain Reduction (VAS Pain Score change of > -33% compared to baseline)
VAS Pain Score change of \> -33% compared to baseline
Time frame: 90, 180 and 360 days
Functional Improvement (-Barthel Index of Activities of Daily Living (ADLs) improvement of > +10% from baseline, -EORTC QLQ-C30 improvement of > +10% from baseline -EORTC QLQ-BM22 improvement of > +10% from baseline)
* Barthel Index of Activities of Daily Living (ADLs) improvement of \> +10% from baseline, * EORTC QLQ-C30 improvement of \> +10% from baseline * EORTC QLQ-BM22 improvement of \> +10% from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Medisch Spectrum Twente
Enschede, Netherlands
Medical Center Leeuwarden
Leeuwarden, Netherlands
Time frame: 90, 180, 360 days
Clinical Safety Success (No Serious Device Related Complications -No additional surgical interventions: revisions, supplements, fixations or removals)
* No Serious Device Related Complications * No additional surgical interventions: revisions, supplements, fixations or removals
Time frame: 90, 180, 360 days
Radiographic Safety Success (No device fracture, migrations, mal-alignment or loss of reduction or fixation)
No device fracture, migrations, mal-alignment or loss of reduction or fixation
Time frame: 90, 180, 360 days
Duration of index procedure and length of hospital stay
Time frame: 90, 180, 360 days
Disability status
Determined per Investigator assessment
Time frame: 90, 180, 360 days
Evaluation of duration of physical therapy prescription
Time frame: 90, 180, 360 days
Assessment of prescription and over-the-counter analgesic medication use
Time frame: 90, 180, 360 days
Survivability from time of index procedure to death
Time frame: 90, 180, 360 days
Incidence and number of AEs
Time frame: 90, 180, 360 days
Incidence and number of procedure- and device-related complications
Time frame: 90, 180, 360 days
Activities of Daily Living score through all follow-up intervals
Barthel Index of Activities of Daily Living (ADLs), EORTC QLQ-C30 and EORTC QLQ-BM22
Time frame: 90, 180, 360 days
VAS Pain score from baseline through all follow-up intervals
VAS pain scale
Time frame: 90, 180, 360 days